insights_auto
Why is ORX down 3,18%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
5,18 SEK
arrow_downward
-3,18%(-0,17) 1D
22-окт., 17:29:40 GMT+2 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
5,00 SEK
High
5,43 SEK
Low
4,95 SEK
Mkt. cap
181,96 млн
Avg. vol.
115,34 миң
Volume
153,90 миң
P/E ratio
0,22
52-wk high
38,75 SEK
52-wk low
4,95 SEK
EPS
23,61 SEK
Shares outstanding
35,13 млн
No. of employees
61
Open
5,00 SEK
High
5,43 SEK
Low
4,95 SEK
Mkt. cap
181,96 млн
Avg. vol.
115,34 миң
Volume
153,90 миң
P/E ratio
0,22
52-wk high
38,75 SEK
52-wk low
4,95 SEK
EPS
23,61 SEK
Shares outstanding
35,13 млн
No. of employees
61
News stories
From web sources and news partners
Investing.com
·
5 саат мурун
Earnings call transcript: Orexo Q3 2026 loss deepens as shares fall 7.1%
Investing.com Canada
·
5 саат мурун
Orexo Q3 2026 slides: platform shift advances despite deepening losses By Investing.com
www.marketscreener.com
·
6 саат мурун
Orexo AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026
TradingView
·
13 саат мурун
Sweden's Orexo Q3 revenue falls sharply, net loss widens
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB